[1
]
From Brigham and Women's Hospital (L.R.B.), Boston, and Moderna, Cambridge (H.B.,
R.P., C.K., B.L., W.D., H.Z., S.H., M.I., J. Miller, T.Z.) - both in Massachusetts;
Baylor College of Medicine (H.M.E.S.) and Centex Studies (J.S.) - both in Houston;
Meridian Clinical Research, Savannah (B.E., S.K., A.B.), and Emory University (N.R.)
and Atlanta Clinical Research Center (N.S.), Atlanta - all in Georgia; University
of Maryland School of Medicine, Baltimore (K.K., K.N.), and National Institute of
Allergy and Infectious Diseases, Bethesda (D.F., M.M., J. Mascola, L.P., J.L., B.S.G.)
- both in Maryland; Saint Louis University School of Medicine, St. Louis (S.F.); University
of Illinois, Chicago, Chicago (R.N.); George Washington University School of Medicine
and Health Sciences, Washington, DC (D.D.); University of California, San Diego, San
Diego (S.A.S.); Vanderbilt University School of Medicine, Nashville (C.B.C.); Quality
of Life Medical and Research Center, Tucson, AZ (J. McGettigan); Johnson County Clin-Trials,
Lenexa, KS (C.F.); Research Centers of America, Hollywood, FL (H.S.); and Fred Hutchinson
Cancer Research Center, Seattle (L.C., P.G., H.J.).